CO2018008288A2 - Ortomixo type tilapia virus - Google Patents
Ortomixo type tilapia virusInfo
- Publication number
- CO2018008288A2 CO2018008288A2 CONC2018/0008288A CO2018008288A CO2018008288A2 CO 2018008288 A2 CO2018008288 A2 CO 2018008288A2 CO 2018008288 A CO2018008288 A CO 2018008288A CO 2018008288 A2 CO2018008288 A2 CO 2018008288A2
- Authority
- CO
- Colombia
- Prior art keywords
- virus
- ortomixo
- type tilapia
- tilapia virus
- type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
El presente documento describe el aislamiento y caracterización de un virus de ARN de pez recientemente descubierto. También se describen métodos para la detección del virus aislado, una vacuna de virus atenuado vivo y una vacuna de virus inactivado.This document describes the isolation and characterization of a recently discovered fish RNA virus. Methods for the detection of the isolated virus, a live attenuated virus vaccine and an inactivated virus vaccine are also described.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662276873P | 2016-01-10 | 2016-01-10 | |
US201662352570P | 2016-06-21 | 2016-06-21 | |
PCT/IL2017/050027 WO2017118989A1 (en) | 2016-01-10 | 2017-01-10 | Orthomyxo-like virus of tilapia |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2018008288A2 true CO2018008288A2 (en) | 2018-08-21 |
Family
ID=59274499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2018/0008288A CO2018008288A2 (en) | 2016-01-10 | 2018-08-06 | Ortomixo type tilapia virus |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3400007A4 (en) |
CN (1) | CN108778324A (en) |
BR (1) | BR112018014042A2 (en) |
CO (1) | CO2018008288A2 (en) |
MX (1) | MX2018008529A (en) |
WO (1) | WO2017118989A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108624718A (en) * | 2018-06-20 | 2018-10-09 | 上海海洋大学 | Constant temperature detects the RPA kits and its primer special and probe of Tilapia mossambica lake virus in real time |
CA3167972A1 (en) | 2020-02-17 | 2021-08-26 | Assaf LOWENTHAL | Immune-enhanced aquaculture |
CN112194710A (en) * | 2020-08-19 | 2021-01-08 | 佛山科学技术学院 | Recombinant protein coded by tilapia lake virus S8 gene, antibody prepared from recombinant protein and application of recombinant protein |
NL2028806B1 (en) * | 2021-07-22 | 2022-06-03 | Univ Northwest A&F | Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus |
CN113718061B (en) * | 2021-09-30 | 2023-06-09 | 厦门海关技术中心 | Primer set, kit and method for simultaneously detecting double RT-PCR of rochu virus and viral nervous necrosis virus |
CN113755645B (en) * | 2021-09-30 | 2023-06-09 | 厦门海关技术中心 | Fluorescent quantitative RT-PCR primer pair and probe for detecting rochu virus, kit and detection method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL230970A0 (en) * | 2014-02-13 | 2014-09-30 | Univ Ramot | Tilapia lake virus vaccines |
SG10202102695UA (en) * | 2014-12-15 | 2021-04-29 | Univ Columbia | Novel tilapia virus and uses thereof |
-
2017
- 2017-01-10 MX MX2018008529A patent/MX2018008529A/en unknown
- 2017-01-10 WO PCT/IL2017/050027 patent/WO2017118989A1/en active Application Filing
- 2017-01-10 BR BR112018014042-2A patent/BR112018014042A2/en not_active Application Discontinuation
- 2017-01-10 CN CN201780015550.2A patent/CN108778324A/en active Pending
- 2017-01-10 EP EP17735934.6A patent/EP3400007A4/en not_active Withdrawn
-
2018
- 2018-08-06 CO CONC2018/0008288A patent/CO2018008288A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2018008529A (en) | 2019-06-06 |
WO2017118989A1 (en) | 2017-07-13 |
EP3400007A4 (en) | 2019-08-28 |
EP3400007A1 (en) | 2018-11-14 |
BR112018014042A2 (en) | 2019-02-12 |
CN108778324A (en) | 2018-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018008288A2 (en) | Ortomixo type tilapia virus | |
EA201790532A1 (en) | METHODS AND COMPOSITIONS FOR REDUCING IMMUNE RESPONSES AGAINST VIRUS VECTOR FOR TRANSFER | |
PH12017500858A1 (en) | Mocrocyclic peptides useful as immunomodulators | |
EA201890493A1 (en) | Htt repressors and their use | |
EA030115B9 (en) | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
MA40765A (en) | METHODS AND COMPOSITIONS FOR INDUCTION OF PROTECTIVE IMMUNITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS INFECTION | |
MX2020004543A (en) | Zika vaccines and immunogenic compositions, and methods of using the same. | |
CU24580B1 (en) | ATTENUATED VECTORS OF INFLUENZA FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AND FOR THE TREATMENT OF ONCOLOGICAL DISEASES | |
MY179251A (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
CL2018000513A1 (en) | Pestivirus vaccines for congenital tremors | |
EA202091567A1 (en) | CHIMERIC PROTEINS MIT | |
EP3104883A4 (en) | Tilapia lake virus vaccines | |
MX2018014955A (en) | Equine influenza virus live-attenuated vaccines. | |
PE20190225A1 (en) | A METHOD TO REDUCE EGG CONTAMINATION | |
CL2016002256A1 (en) | An improved process for the preparation of exametazyme | |
EP3600404A4 (en) | Development of an alternative modified live influenza b virus vaccine | |
AR103281A1 (en) | COMPOSITIONS, APPLIANCES AND METHODS TO DETERMINE THE pH OF AN ANALYTIC SOLUTION | |
CL2022001509A1 (en) | Inactivated fish orthoreovirus vaccine. | |
杨李琼 | Host | |
侯荣彦 | It’s Me | |
CL2019000555S1 (en) | Blender. | |
呱呱 | HEROS | |
弗朗兹 | Message from guest | |
彭荣华 | Talking About Festivals | |
李维国 | Photo News |